BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1297561)

  • 1. [Treatment of Guillain-Barré syndrome with "axonal" involvement by plasma exchange].
    Mezaki T; Kaji R; Kimura J; Shibasaki H
    Rinsho Shinkeigaku; 1992 Oct; 32(10):1140-2. PubMed ID: 1297561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal form of Guillain-Barré syndrome: evidence for macrophage-associated demyelination.
    Berciano J; Coria F; Montón F; Calleja J; Figols J; LaFarga M
    Muscle Nerve; 1993 Jul; 16(7):744-51. PubMed ID: 8505931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
    Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV
    Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1997 Mar; 41(3):298-306. PubMed ID: 9066350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1992 Jul; 32(1):94-7. PubMed ID: 1642477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. There are no neurophysiologic features characteristic of "axonal" Guillain-Barré syndrome.
    Cros D; Triggs WJ
    Muscle Nerve; 1994 Jun; 17(6):675-7. PubMed ID: 8196711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome.
    Ann Neurol; 1987 Dec; 22(6):753-61. PubMed ID: 2893583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of the motor-sensory axonal Guillain-Barré syndrome.
    Griffin JW; Li CY; Ho TW; Tian M; Gao CY; Xue P; Mishu B; Cornblath DR; Macko C; McKhann GM; Asbury AK
    Ann Neurol; 1996 Jan; 39(1):17-28. PubMed ID: 8572662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin].
    Imai N; Miyata K; Terayama Y; Ishihara N
    Rinsho Shinkeigaku; 1997 Jun; 37(6):520-2. PubMed ID: 9366182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Guillain-Barré syndrome: sorting out the pathological hallmark in an electrophysiological axonal case.
    Berciano J; García A; Villagrá NT; González F; Ramón C; Illa I; Berciano MT; Lafarga M
    J Peripher Nerv Syst; 2009 Mar; 14(1):54-63. PubMed ID: 19335540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
    Dididze MN
    Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
    Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement.
    Dada MA; Kaplan AA
    Ther Apher Dial; 2004 Oct; 8(5):409-12. PubMed ID: 15663537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma exchange treatment in chronic polyneuritis of the Guillain-Barré type. Experiences with 9 personal cases].
    Gibbels E; Toyka KV; Borberg H; Haupt WF; Hann P
    Nervenarzt; 1986 Mar; 57(3):129-39. PubMed ID: 3960229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal Guillain-Barré syndrome.
    Feasby TE
    Muscle Nerve; 1994 Jun; 17(6):678-9. PubMed ID: 8196712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum demyelinating activity and Guillain-Barre syndrome: favorable effect of plasma exchange].
    Metral S; Raphael JC; Hort-Legrand CI; Elkharrat D
    Rev Neurol (Paris); 1989; 145(4):312-9. PubMed ID: 2660223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic inflammatory demyelinating polyradiculoneuropathy of acute onset: relapse after temporary improvement by plasma exchange and longstanding remission by corticosteroid therapy].
    Iwatsubo T; Sakanaka C; Obi T; Takeda K; Sakuta M
    Rinsho Shinkeigaku; 1989 Jul; 29(7):930-2. PubMed ID: 2805518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré syndrome after bone marrow transplantation.
    Perry A; Mehta J; Iveson T; Treleaven J; Powles R
    Bone Marrow Transplant; 1994 Jul; 14(1):165-7. PubMed ID: 7951108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute "axonal" Guillain-Barré syndrome in childhood.
    Reisin RC; Cersósimo R; García Alvarez M; Massaro M; Fejerman N
    Muscle Nerve; 1993 Dec; 16(12):1310-6. PubMed ID: 8232386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.